Plasma Junctional Adhesion Molecule C Levels Are Associated with the Presence and Severity of Coronary Artery Disease.
暂无分享,去创建一个
Qing Zhang | Hongchun Wang | Ye-min Zhang | Hengzhe Zhang | Zhenguo Wu | Li Liu | Huiliang Cui | Jianmin Yang | Zaibao Liu
[1] Guang Wang,et al. Sex Difference in the Association Between Neutrophil to Lymphocyte Ratio and Severity of Coronary Artery Disease , 2022, Angiology.
[2] P. Libby. Inflammation during the life cycle of the atherosclerotic plaque. , 2021, Cardiovascular research.
[3] E. Kızıltunç,et al. Relationship Between Systemic Immune-Inflammation Index (SII) and the Severity of Stable Coronary Artery Disease , 2021, Angiology.
[4] Francesca N. Delling,et al. Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association , 2020, Circulation.
[5] Dong Li,et al. Association of platelet to lymphocyte ratio with in-hospital major adverse cardiovascular events and the severity of coronary artery disease assessed by the Gensini score in patients with acute myocardial infarction , 2020, Chinese medical journal.
[6] E. Fisher,et al. Divergent JAM-C Expression Accelerates Monocyte-Derived Cell Exit from Atherosclerotic Plaques , 2016, PloS one.
[7] H. Suryapranata,et al. Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease , 2016, Angiology.
[8] A. Zernecke,et al. Importance of Junctional Adhesion Molecule-C for Neointimal Hyperplasia and Monocyte Recruitment in Atherosclerosis-Prone Mice–Brief Report , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[9] S. Jimenez,et al. The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1. , 2009, Rheumatology.
[10] Jordan S. Pober,et al. Evolving functions of endothelial cells in inflammation , 2007, Nature Reviews Immunology.
[11] F. Luscinskas,et al. JAM-C regulates unidirectional monocyte transendothelial migration in inflammation. , 2007, Blood.
[12] M. Aurrand-Lions,et al. Expression and function of junctional adhesion molecule-C in human and experimental arthritis , 2007, Arthritis research & therapy.
[13] M. Schaller,et al. Platelets Recruit Human Dendritic Cells Via Mac-1/JAM-C Interaction and Modulate Dendritic Cell Function In Vitro , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[14] Song-min Huang,et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.
[15] M. Aurrand-Lions,et al. The role of junctional adhesion molecule C (JAM‐C) in acute pancreatitis , 2006, The Journal of pathology.
[16] E. Chavakis,et al. The role of junctional adhesion molecule‐C (JAM‐C) in oxidized LDL‐mediated leukocyte recruitment , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] S. Nourshargh,et al. Junctional Adhesion Molecule-C Regulates the Early Influx of Leukocytes into Tissues during Inflammation1 , 2005, The Journal of Immunology.
[18] G. Hansson. Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.
[19] K. Preissner,et al. The Junctional Adhesion Molecule-C Promotes Neutrophil Transendothelial Migration in Vitro and in Vivo* , 2004, Journal of Biological Chemistry.
[20] P. Libby,et al. Inflammation and Atherosclerosis , 2002, Circulation.
[21] S. Cunningham,et al. Cloning of Human Junctional Adhesion Molecule 3 (JAM3) and Its Identification as the JAM2 Counter-receptor* , 2001, The Journal of Biological Chemistry.
[22] D. Granger,et al. Adhesion molecules and their role in vascular disease. , 2001, American journal of hypertension.
[23] M. Aurrand-Lions,et al. JAM-2, a Novel Immunoglobulin Superfamily Molecule, Expressed by Endothelial and Lymphatic Cells* , 2001, The Journal of Biological Chemistry.
[24] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[25] J. K. Lloyd,et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.
[26] G. Gensini,et al. A more meaningful scoring system for determining the severity of coronary heart disease. , 1983, The American journal of cardiology.